STUB1 and hematologic disorder: Moreover, recent studies have shown the additive impact of mCAs and CHIP mutations on predisposition to blood cancers, with respect to overall risk for a primary hematologic malignancy and also in the setting of therapy-associated myeloid malignancies10,11, but do not systematically examine genetic relationships which can inform shared mechanisms.